InvestorsHub Logo
Followers 6
Posts 1924
Boards Moderated 0
Alias Born 09/26/2007

Re: Tsponberg post# 2361

Tuesday, 09/01/2020 9:23:57 PM

Tuesday, September 01, 2020 9:23:57 PM

Post# of 3547
So from the presentation we learned that:

- the prototype is NOT yet complete.

- the testing at Mayo Clinic has NOT yet begun.

- the testing will be done at multiple clinics - (number not given)

- uplist will be event driven which we knew before. It probably refers to a PR about the completion of the prototype and/or perhaps testing results so I assume that it will still be a while until that happens.

- Once the application for approval is submitted to the FDA, they have 5 months to respond.

- Conservatively, sales should begin by the end of next year which is a bit later than they had originally thought, but Covid-19 issues seem to have slowed some things down. Nothing we can do about that.

- Next capital raise will probably be at the time of the IPO or soon afterwards. They have enough capital to get them to that point. Monthly burn is about $200K? I think that is what he said.

- They are aware of competitors and still think they will have the advantage of being first to market. My understanding is that most other competitors are not working on a wearable as their first product, but rather a device for clinics or portable device for home. Two competitors, PavMed and Nemauro, will present later this week as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News